Adenosquamous lung carcinoma

From WikiMD's WELLNESSPEDIA


Adenosquamous lung carcinoma
Synonyms
Pronounce N/A
Specialty Oncology, Pulmonology
Symptoms Cough, Hemoptysis, Chest pain, Dyspnea
Complications Metastasis, Pleural effusion
Onset
Duration
Types
Causes Smoking, Genetic mutations
Risks Tobacco smoking, Exposure to carcinogens
Diagnosis Biopsy, Imaging studies
Differential diagnosis Adenocarcinoma, Squamous cell carcinoma
Prevention Smoking cessation, Avoidance of carcinogens
Treatment Surgery, Chemotherapy, Radiation therapy
Medication Cisplatin, Paclitaxel
Prognosis Variable, depends on stage and treatment response
Frequency Rare
Deaths


Adenosquamous lung carcinoma is a rare type of lung cancer that contains both adenocarcinoma and squamous cell carcinoma components. It accounts for approximately 0.4% to 4% of all lung cancers.

Etiology[edit]

The exact cause of adenosquamous lung carcinoma is unknown. However, it is believed to be associated with smoking, similar to other types of lung cancer.

Pathogenesis[edit]

Adenosquamous lung carcinoma is characterized by the presence of both glandular (adenocarcinoma) and squamous differentiation. The tumor cells often show a mixture of these two components, although one component may dominate over the other.

Clinical Features[edit]

Patients with adenosquamous lung carcinoma often present with symptoms similar to other types of lung cancer, such as cough, chest pain, and weight loss. However, due to the squamous component of the tumor, these patients may also present with hemoptysis (coughing up blood).

Diagnosis[edit]

The diagnosis of adenosquamous lung carcinoma is made by histopathological examination of a biopsy specimen. The presence of both adenocarcinoma and squamous cell carcinoma components is required for the diagnosis.

Treatment[edit]

The treatment of adenosquamous lung carcinoma is similar to other types of lung cancer and may include surgery, radiation therapy, and chemotherapy. However, due to the aggressive nature of this type of cancer, the prognosis is often poor.

Prognosis[edit]

The prognosis of adenosquamous lung carcinoma is generally poor, with a 5-year survival rate of less than 15%. The poor prognosis is due to the aggressive nature of the tumor and the often advanced stage at diagnosis.

See Also[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.